Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2011
October 2011, Vol 2, No 6
Jayson Slotnik, JD, MPH
Managing Partner
Health Policy Strategies, Inc.
Bethesda, MD
Authored Articles
August 13, 2020: Washington and Public Policy Update: COVID-19 Recovery, the Road Ahead
Deborah Kamin, RN, PhD
,
Ted Okon, MBA
,
John O’Brien, PharmD, MPH
,
Jayson Slotnik, JD, MPH
,
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
AVBCC COVID-19 Webcast Series
Read Article
May 20, 2020: Washington and Public Policy: COVID-19 Impact on Cancer Care and Road to Recovery
Deborah Kamin, RN, PhD
,
Ted Okon, MBA
,
John O’Brien, PharmD, MPH
,
Jayson Slotnik, JD, MPH
,
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
AVBCC COVID-19 Webcast Series
Read Article
Washington and Public Policy: The COVID-19 Pandemic
Scott Gottlieb, MD
,
Jayson Slotnik, JD, MPH
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
AVBCC COVID-19 Webcast Series
Read Article
Up Next for the Center for Medicare and Medicaid Innovation: Cancer
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
May 2014, Vol 5, No 4
Read Article
Improving Patient Access, Initiation, and Adherence Abstract
Jayson Slotnik, JD, MPH
April 2014, Vol 5, No 3
Read Article
Benefit Design and Coverage Trends Abstract
Jayson Slotnik, JD, MPH
April 2014, Vol 5, No 3
Read Article
Advocacy and Community Involvement Abstract
Jayson Slotnik, JD, MPH
April 2014, Vol 5, No 3
Read Article
Value Propositions
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
April 2014, Vol 5, No 3
Read Article
Dovitinib Active but Not Superior to Sorafenib in Patients with Metastatic Renal Cancer
Jayson Slotnik, JD, MPH
In the Literature
April 2014, Vol 5, No 3
Read Article
Rituximab Active in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Jayson Slotnik, JD, MPH
In the Literature
April 2014, Vol 5, No 3
Read Article
Personalizing Targeted Treatment Possible for Advanced Breast Cancer
Jayson Slotnik, JD, MPH
In the Literature
April 2014, Vol 5, No 3
Read Article
Bevacizumab Does Not Improve Survival in Patients with Newly Diagnosed Glioblastoma
Jayson Slotnik, JD, MPH
In the Literature
March 2014, Vol 5, No 2
Read Article
Implications of the Affordable Care Act for Adult Survivors of Childhood Cancer
Jayson Slotnik, JD, MPH
In the Literature
March 2014, Vol 5, No 2
Read Article
Nintedanib plus Docetaxel an Effective Combination in Patients with Advanced Non–Small-Cell Lung Cancer
Jayson Slotnik, JD, MPH
In the Literature
March 2014, Vol 5, No 2
Read Article
Bortezomib plus Thalidomide Maintenance Therapy Improves Overall Survival in Transplant-Ineligible Patients with Newly Diagnosed Myeloma
Jayson Slotnik, JD, MPH
In the Literature
March 2014, Vol 5, No 2
Read Article
Value Propositions
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
March 2014, Vol 5, No 2
Read Article
Dual-Vaccine Combination Improves Survival in Patients with Metastatic Pancreatic Cancer
Jayson Slotnik, JD, MPH
GI Cancers Symposium
February 2014, Vol 5, No 1
Read Article
Ibrutinib Approved for Chronic Lymphocytic Leukemia
Jayson Slotnik, JD, MPH
FDA Approvals, News & Updates
February 2014, Vol 5, No 1
Read Article
First Drug Combination Approved for Unresectable or Metastatic Melanoma
Jayson Slotnik, JD, MPH
FDA Approvals, News & Updates
February 2014, Vol 5, No 1
Read Article
Aetna Announced First Patient-Centered Medical Home in Oncology
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Read Article
M.D. Anderson’s Scientists Collaborate with Pfizer to Enhance Immunotherapy in Oncology
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Read Article
ASCO Launches Value in Cancer Care Initiative
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Read Article
NCI Pilot Trial to Assess Value of Genetic Sequencing for Improving Patient Outcomes
Jayson Slotnik, JD, MPH
Value Propositions
,
Value Peer-spectives
February 2014, Vol 5, No 1
Read Article
Statin Therapy Lowers Mortality in Patients with Prostate Cancer
Jayson Slotnik, JD, MPH
In the Literature
February 2014, Vol 5, No 1
Read Article
New Gene Mutation Identified in Myeloproliferative Neoplasms
Jayson Slotnik, JD, MPH
In the Literature
February 2014, Vol 5, No 1
Read Article
Adverse Events Reporting Suboptimal in Oncology Publications
Jayson Slotnik, JD, MPH
In the Literature
February 2014, Vol 5, No 1
Read Article
Obinutuzumab Outperforms Rituximab in Older Patients with CLL
Jayson Slotnik, JD, MPH
In the Literature
February 2014, Vol 5, No 1
Read Article
Medicare Committee Gives Thumbs Down to New Genetic Tests for Cancer
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
June 2013, Vol 4, No 5
Read Article
Time to Review Practice Policies: HIPAA Privacy and Security Regulations Released
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
February 2013, Vol 4, No 2
Read Article
CMS Finalizes Payment Policies for 2013, Signaling a Shift toward Paying for Value
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
November 2012, Vol 3, No 8
Read Article
The Affordable Care Act: The Day of Reckoning Arrives
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
July 2012, Vol 3, No 5
Read Article
US Preventive Services Task Force and the Future of Prostate Cancer Screening
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
October 2011, Vol 2, No 6
Read Article
Hanging in Limbo: What Does Deficit Reduction Mean for Oncology?
Ross D. Margulies, JD, MPH
,
Jayson Slotnik, JD, MPH
Health Policy
,
Policies & Guidelines
August 2011, Vol 2, No 5
Read Article
CMS-FDA Proposed Premarket Parallel Review—The Devil is in the Details
Jayson Slotnik, JD, MPH
October 2010, Vol 1, No 5
Read Article
Premarket Policies May Generate the Best Value
Jayson Slotnik, JD, MPH
Value-Based Care
,
VBCC Perspectives
June 2010, Vol 1, No 2
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
Talvey Receives Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma